Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. (KLRA) priced its initial public offering on Apr 17, 2026 at $16.00 per share, within its $14.00–$16.00 range, raising $625M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.98B. J.P. Morgan was lead-left underwriter, joined by Jefferies, Leerink Partners and TD Cowen and others. Paul Hastings advised the underwriters.

Status

IPO

Ticker

KLRA

Exchange

Nasdaq Global Select

Priced

Apr 17, 2026

IPO price

$16.00

Price range

$14.00–$16.00

Raised

$625M

Market cap at IPO price

$1.98B

First filed

Mar 27, 2026

Underwriters

J.P. Morgan, Jefferies, Leerink Partners, TD Cowen, Evercore ISI and William Blair

Underwriters' counsel

Paul Hastings

Sector

Biotech & pharma

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.